ArticleAnnals of medicine2026
The prevalence and predictors of previous prostate cancer screening among men attending primary healthcare centers in Riyadh, Saudi Arabia.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly detection through screening is crucial for improving treatment outcomes and reducing disease burden. . This study investigates the predictors of previous prostate cancer screening among Saudi men attending primary healthcare centers (PHCs) in Riyadh, Saudi Arabia.
methodsA cross-sectional study was conducted from March to July 2023, involving 6,177 men attending 48 PHCs in Riyadh, selected
resultsA total of 6,177 men participated in the study. Age distribution was 31% under 50, 48.4% aged 50-75, 20.5% 75+ years . Only 1.5% of participants reported having undergone previous prostate cancer screening. crude proportions of screening were 0.9%, 1.7%, and 1.3% for the <50, 50 - 75, and ≥75 age groups, respectively. In adjusted analysis, age 50-75 years (AOR: 3.07, 95% CI: 1.73-5.46), unemployment (AOR: 3.69, 95% CI: 2.33-5.85), health insurance coverage (AOR: 2.98, 95% CI: 1.93-4.61), smoking (AOR: 4.52, 95% CI: 2.73-7.49), and history of heart disease (AOR: 3.04, 95% CI: 1.44-6.42) were significant predictors of previous prostate cancer screening.
conclusionThe extremely low prevalence of previous prostate cancer screening in this population underscores urgent need to improve access to PSA testing. Employment status, insurance coverage, smoking, and history of heart disease were significant predictors of screening uptake. These findings highlight need for both targeted and general interventions and support development of a national strategy for PSA testing among asymptomatic men in Saudi Arabia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.